Early 30-day results from a prospective, real-world registry of the Abre venous self-expanding stent system (Medtronic) showed ...

Thrombolex, Inc., announced interim results from the first 150 patients enrolled in its RAPID-PE postmarket study, a ...

Endovascular Engineering, Inc. (E2), a developer of technology for venous thromboembolism, announced FDA 510(k) clearance for b ...

AngioDynamics, Inc. announced the appointment of Eric Honroth as President, Chief Executive Officer, and a member of the company ...

Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

Frank J. Veith, MD, Chairman of the VEITHsymposium, announced that Gustavo S. Oderich, MD, will be assuming the role of the org ...

B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that ...

Reva Medical, LLC announced the presentation of results from a subgroup analysis of the MOTIV BTK pivotal trial for the ...

BD (Becton, Dickinson and Company) announced 9-month results from the iliac cohort of the AGILITY investigational device ...

Johnson & Johnson MedTech announced 24-month results from the DISRUPT PAD BTK II postmarket study assessing the continued sa ...

Cordis announced that its Selution SLR Sustane percutaneous transluminal angioplasty (PTA) sirolimus drug-eluting balloon ...

Penumbra, Inc., announced new STORM-PE findings examining the relationship between activity recorded by wearable devices and cli ...